Otro problema es que el aceite CBD que pidas posiblemente no contenga lo que debe. Un estudio de 2017 de 84 productos vendidos en línea encontró que solamente un 31% contenía la cantidad de CBD que decía la etiqueta. Por otro lado, un 42% de los productos contenían más de lo que indicaba en la etiqueta, y un 26% contenía menos de lo que señalaba la etiqueta.
Nothing soothes as quickly or as thoroughly as Polar Lotion - a new therapeutic lotion that brings long-lasting, deep-cooling relief to your massage. Fast-penetrating, it immediately quiets aching, inflamed, or sore areas to bring overall comfort. Ideal for sports training, physical therapy, or combined with a stretching program. Non-lingering aroma.
Esta encuesta – una colaboración entre Care By Design y Project CBD – buscó la respuesta a varias preguntas: ¿Qué tan satisfechos están los pacientes con el Cannabis como analgésico?¿Cómo se compara la marihuana medicinal con otros enfoques de manejo del dolor, en particular, con opiáceos? ¿Cómo se comparan las terapias de manejo del dolor más comunes en términos de su impacto en la calidad de vida?
As a dorky kid, I spent many a Saturday at the Bloomington, Ind., public library, scouring Consumer Reports back issues for great deals. Now, as a (much) bigger kid, that's still my job! Identifying products and services, especially in healthcare, that are safe, effective, and affordable—and highlighting those that aren't—is my top concern. Got a tip? Follow me on Twitter (@Lisa_L_Gill)
A. No. Under section 301(ll) of the FD&C Act, it is prohibited to introduce or deliver for introduction into interstate commerce any food (including any animal food or feed) to which has been added a substance which is an active ingredient in a drug product that has been approved under 21 U.S.C. § 355 (section 505 of the Act) or a drug for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public. There are exceptions, including when the drug was marketed in food before the drug was approved or before the substantial clinical investigations involving the drug had been instituted or, in the case of animal feed, that the drug is a new animal drug approved for use in feed and used according to the approved labeling. However, based on available evidence, FDA has concluded that none of these is the case for THC or CBD. FDA has therefore concluded that it is a prohibited act to introduce or deliver for introduction into interstate commerce any food (including any animal food or feed) to which THC or CBD has been added. FDA is not aware of any evidence that would call into question these conclusions. Interested parties may present the agency with any evidence that they think has bearing on this issue. Our continuing review of information that has been submitted thus far has not called our conclusions into question.
There is an exception to sections 201(ff)(3)(B)(i) and (ii) if the substance was "marketed as" a dietary supplement or as a conventional food before the drug was approved or before the new drug investigations were authorized, as applicable. However, based on available evidence, FDA has concluded that this is not the case for THC or CBD. For more information on this provision, including an explanation of the phrase "marketed as," see Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues.